Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
M3 ( (JP:2413) ) just unveiled an update.
M3, Inc. has announced the repurchase of its own common shares, with a total of 277,500 shares repurchased for 538,486,250 yen between May 3 and May 31, 2025. This move is part of a larger plan approved by the Board of Directors to repurchase up to 20 million shares, valued at a maximum of 20 billion yen, by April 30, 2026. The repurchase is conducted through open market purchases on the Tokyo Stock Exchange, and the company notes that the actual number of shares repurchased may vary based on market conditions.
The most recent analyst rating on (JP:2413) stock is a Buy with a Yen3300.00 price target. To see the full list of analyst forecasts on M3 stock, see the JP:2413 Stock Forecast page.
More about M3
M3, Inc. operates in the healthcare industry, focusing on providing medical-related services and products. The company is known for its online medical platforms and services that cater to healthcare professionals and institutions.
Average Trading Volume: 3,926,191
Technical Sentiment Signal: Hold
Current Market Cap: Yen1476.9B
For a thorough assessment of 2413 stock, go to TipRanks’ Stock Analysis page.